<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-98680</identifier>
<setSpec>0210-5705</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Enteropathy-associated intestinal t-cell lymphoma without celiac disease</dc:title>
<dc:description xml:lang="en">Type II enteropathy-associated T-cell lymphoma (EATL) is an uncommon intestinal lymphoma. We report the case of a 73-year-old man with diarrhea and weight loss. Duodenal biopsy showed atrophy and infiltration of irregular lymphocytes. Immunohistochemistry was positive for CD3, CD8, and CD56 with monoclonal TCR rearrangement. The HLA-DQ genotype was DQ5/DQ9. The Epstein-Barr virus RNA test was negative. Before specific chemotherapy could be administered, the patient was admitted to hospital for a respiratory infection and died from a cause unrelated to his lymphoma. The differential diagnosis of CD56-positive lymphoproliferative processes include type II EATL, primary T-cell/natural killer-cell intestinal lymphoma and hepatosplenic  T-cell lymphoma. The patient had CD8 y CD56+ markers that allowed type I EATL to be excluded. The HLA-DQ genotype did not correspond to celiac disease and the biopsy showed proliferation of lymphocytes with atypia. The primary intestinal T-cell/natural killer-cell lymphoma was characterized mainly by the absence of CD8 and monoclonal reassortment of the TCR present in this case (AU)</dc:description>
<dc:creator>Arias, Laura</dc:creator>
<dc:creator>Alvarado, María G</dc:creator>
<dc:creator>Calleja, Sara</dc:creator>
<dc:creator>Vaquero, Luis</dc:creator>
<dc:creator>Diez-Tascón, Cristina</dc:creator>
<dc:creator>Hernando, Mercedes</dc:creator>
<dc:creator>Vivas, Santiago</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La enteropatía asociada a linfoma de células T tipo II es un linfoma intestinal infrequente. Presentamos el caso un varón de 73 años con diarrea y pérdida de peso. La biopsia duodenal presentaba atrofia e infiltrado de linfocitos irregulares. La inmunohistoquímica detectó positividad para CD3, CD8, CD56 con reordenamiento monoclonal del TCR. El genotipifación de HLA-DQ era DQ5/DQ9. El test para EBVRNA fue negativo. Antes del tratamiento específico quimioterápico ingresó por infección respiratoria, y falleció por causa independiente del linfoma. El diagnóstico diferencial de los procesos linfoproliferativos CD56-positivo incluye EATL tipo II, linfoma intestinal primario de células T/NK y linfoma de células T hepatoesplénico.El paciente presentaba CD8 y CD56+ marcadores que permiten descartar EALT tipo I. la genotipificación HLA-DQ no corresponde a enfermedad celíaca, y la biopsia presentaba proliferación de linfocitos con atipias. El linfoma intestinal primario de células T/NK se caracteriza principalmente por ausencia de CD8 y del reordenamiento monoclonal del TCR presentes en este caso(AU)</dc:description>
<dc:source>Gastroenterol Hepatol;35(1): 17-21, ene. 2012.</dc:source>
<dc:identifier>ibc-98680</dc:identifier>
<dc:title xml:lang="es">Linfoma intestinal de células T asociado a enteropatía y sin relación con enfermedad celíaca</dc:title>
<dc:subject>^d32842^s22002</dc:subject>
<dc:subject>^d30831^s22002</dc:subject>
<dc:subject>^d53939^s22016</dc:subject>
<dc:subject>^d30260^s22002</dc:subject>
<dc:subject>^d2481^s22016</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d7577^s22053</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:type>article</dc:type>
<dc:date>201201</dc:date>
</metadata>
</record>
</ibecs-document>
